November 14, 2010
1st Annual Atlanta Undy 5000 5K Debuts Strong
Race Participants Raise Significant Funds to Help Build Colon Cancer Programs
Atlanta, GA (November 14, 2010) – The Colon Cancer Alliance’s 1st Annual Atlanta Undy 5000 5K run was held on Saturday, November 13 in historic downtown Decatur. More than 350 people, including 20 colon cancer survivors, participated in the event designed to bring greater awareness to colon cancer, the 2nd leading cause of cancer death in the United States.
“The first annual Atlanta Undy 5000 was one of the most successful first-time events in the 2010 Undy 5000 series,” said Andrew Spiegel, CEO of the Colon Cancer Alliance (CCA). “Atlanta helped raise almost $70,000 to support and build the CCA’s national and local patient support and public awareness programs. We are looking forward to coming back to Atlanta in 2011!”
The Undy 5000 series, created by the CCA and held in cities across the nation, is designed to promote awareness and education about colon cancer. The event stresses the importance of timely colon cancer screening, and provides valuable information for those already affected by the disease. The American Cancer Society estimates that 142,000 new cases will be diagnosed this year. Through recommended screenings, this cancer can be caught early when treatment is most effective — or even prevented altogether when pre-cancerous polyps are detected and removed.
Local sponsors of the event included General Mills, Dole and Coyote Logistics. National sponsors of this event included Amgen Oncology, ASCRS (American Society of Colon and Rectal Surgeons), Bristol Myers Squibb, Ethicon Endo-Surgery, Genentech, MITA (Medical Imaging and Technology Alliance) and Salix Pharmaceuticals.
More information about the Undy 5000 is available online at www.undy5000.org.
# # #
The Colon Cancer Alliance (CCA) is a national patient advocacy organization dedicated to ending the suffering caused by colorectal cancer. In order to increase rates of screening and survivorship, the CCA provides patient support, public education, supports research and conducts advocacy work across America.